GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Denis Chem Lab Ltd (BOM:537536) » Definitions » Earnings per Share (Diluted)

Denis Chem Lab (BOM:537536) Earnings per Share (Diluted) : ₹8.04 (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Denis Chem Lab Earnings per Share (Diluted)?

Denis Chem Lab's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ₹1.97. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹8.04.

Denis Chem Lab's EPS (Basic) for the three months ended in Mar. 2024 was ₹1.97. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹8.04.

Denis Chem Lab's EPS without NRI for the three months ended in Mar. 2024 was ₹1.97. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was ₹8.04.

During the past 12 months, Denis Chem Lab's average EPS without NRIGrowth Rate was 42.00% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 34.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 17.10% per year.

During the past 12 years, Denis Chem Lab's highest 3-Year average EPS without NRI Growth Rate was 50.00% per year. The lowest was -34.50% per year. And the median was 24.20% per year.


Denis Chem Lab Earnings per Share (Diluted) Historical Data

The historical data trend for Denis Chem Lab's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denis Chem Lab Earnings per Share (Diluted) Chart

Denis Chem Lab Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.03 1.63 4.51 5.66 8.04

Denis Chem Lab Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 1.93 1.83 2.31 1.97

Competitive Comparison of Denis Chem Lab's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Denis Chem Lab's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Denis Chem Lab's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Denis Chem Lab's PE Ratio distribution charts can be found below:

* The bar in red indicates where Denis Chem Lab's PE Ratio falls into.



Denis Chem Lab Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Denis Chem Lab's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (A: Mar. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(111.558-0)/13.875
=8.04

Denis Chem Lab's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(27.293-0)/13.855
=1.97

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Denis Chem Lab  (BOM:537536) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Denis Chem Lab Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Denis Chem Lab's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Denis Chem Lab (BOM:537536) Business Description

Traded in Other Exchanges
N/A
Address
Satellite Road, 401 Abhishree Complex, Opposite OM Tower, Beside Bidiwala Park, Ahmedabad, GJ, IND, 380015
Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.

Denis Chem Lab (BOM:537536) Headlines

No Headlines